3. BrainswayR&D spending: $6,156,000
Percentage of revenues: 37.5%
2019 overall revenue ranking: 99
Brainsway is developing deep transcranial magnetic stimulation to treat brain disorders.
Currently, the system is FDA-cleared to treat depressive episodes in adults who have major depressive disorder and who have not had success with anti-depressant medication treatment.
Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.
